Grantham, Mayo, Van Otterloo & Co (GMO)’s Kadant KAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25M Buy
79,583
+1,530
+2% +$477K 0.06% 157
2026
Q1
$22.8M Buy
78,053
+24,779
+47% +$7.96M 0.06% 171
2025
Q4
$15.2M Sell
53,274
-9,964
-16% -$2.83M 0.04% 206
2025
Q3
$18.8M Buy
63,238
+591
+0.9% +$193K 0.05% 176
2025
Q2
$19.9M Sell
62,647
-6,631
-10% -$2.08M 0.06% 181
2025
Q1
$23.3M Buy
69,278
+15,260
+28% +$5.54M 0.07% 174
2024
Q4
$18.6M Buy
54,018
+2,216
+4% +$804K 0.06% 195
2024
Q3
$17.5M Buy
51,802
+4,914
+10% +$1.57M 0.05% 212
2024
Q2
$13.8M Buy
46,888
+2,687
+6% +$766K 0.05% 241
2024
Q1
$14.5M Sell
44,201
-9,444
-18% -$2.85M 0.05% 223
2023
Q4
$15M Sell
53,645
-3,408
-6% -$853K 0.07% 202
2023
Q3
$12.9M Buy
57,053
+19,047
+50% +$4.12M 0.06% 232
2023
Q2
$8.44M Buy
38,006
+2,564
+7% +$513K 0.04% 276
2023
Q1
$7.39M Buy
35,442
+17,618
+99% +$3.58M 0.04% 281
2022
Q4
$3.17M Buy
17,824
+3,370
+23% +$600K 0.02% 391
2022
Q3
$2.41M Buy
+14,454
New +$2.69M 0.01% 403
2018
Q1
Sell
-3,700
Closed -$371K 602
2017
Q4
$371K Hold
3,700
﹤0.01% 487
2017
Q3
$365K Hold
3,700
﹤0.01% 446
2017
Q2
$278K Buy
+3,700
New +$258K ﹤0.01% 486

Other funds holding KAI

Grantham, Mayo, Van Otterloo & Co (GMO)'s KAI Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Kadant (KAI) stake by 2% in Q2 2026, buying an estimated $477K and bringing the position to 79,583 shares worth $25M. The position accounts for 0.06% of the portfolio, ranked #157.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in KAI in Q2 2017 and has held it in 19 quarters since. 324 funds tracked by Wall St. Rank hold KAI as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 79,583 shares of Kadant worth $25M as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 1,530 Kadant shares in Q2 2026, an estimated $477K.
  • Kadant made up 0.06% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #157 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Kadant in Q2 2017 and has held it in 19 quarters since.
  • 324 funds tracked by Wall St. Rank held Kadant as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.